Tuberculosis (TB) is the most ancient epidemic disease in the world and a serious opportunistic disease in HIV/AIDS patients. The increase in multidrug resistant Mycobacterium tuberculosis (MDR-TB, XDR-TB) demands the search for novel antimycobacterial drugs. Essential oils (EOs) have been widely used in medicine and some EOs and their major components have been shown to be active against M. tuberculosis. The aim of this work was to evaluate the antimycobacterial and cell toxicity activities of three EOs derived from Salvia aratocensis, Turnera diffusa and Lippia americana, aromatics plants collected in Colombia. The EOs were isolated by hydrodistillation and analyzed by GC/MS techniques. The EOs were tested against 15 Mycobacterium spp using a colorimetric macrodilution method and against mammalian Vero and THP-1 cells by MTT. The activity was expressed as minimal concentration in µg/mL that inhibits growth, and the concentration that is cytotoxic for 50 or 90% of the cells (CC 50 and CC 90 ). The major components were epi-α-cadinol (20.1%) and 1,10-diepi-cubenol (14.2%) for Salvia aratocensis; drima-7,9(11)-diene (22.9%) and viridiflorene (6.6%) for Turnera diffusa; and germacrene D (15.4%) and trans-β-caryophyllene (11.3%) for Lippia americana. The most active EO was obtained from S. aratocensis, with MIC values below 125 µg mL -1 for M. tuberculosis Beijing genotype strains, and 200 to 500 µg mL -1 for nontuberculous mycobacterial strains. The EOs were either partially or non toxic to Vero and THP-1 mammalian cells with CC 50 values from 30 to >100 µg mL -1 , and a CC 90 >100 µg mL -1 . The EOs obtained from the three aromatic Colombian plants are an important source of potential compounds against TB. Future studies using the major EO components are recommended.
Human TB is a contagious disease caused mainly by Mycobacterium tuberculosis, an aerobic bacterium that establishes its infection typically in the lungs [1] . About one-third of the world's population is currently infected and 10% of the infected patients could develop a clinical disease, especially those with diverse types of immunodeficiency (i.e. HIV infection, transplant patients, cancer chemotherapy, under nutrition). TB is the leading cause of death worldwide from a single human pathogen and it is estimated that TB active cases occur in 7-8 million people annually and produce 3 million deaths per year [1, 2] .
New TB drugs are necessary for several reasons: 1. to improve the current treatment by shortening the total duration of treatment and/or by providing more widely spaced and intermittent treatment; 2. to improve the treatment of multi-drug resistant (MDR) TB and extremely drug-resistant (XDR) TB; 3. to provide more effective treatment to latent tuberculosis infection; and 4. to abolish side effects, especially hepatotoxicity that in some cases forces an untimely treatment termination [3] [4] [5] . Natural products are a source of potentially active molecules against several types of pathogens, such as parasites, bacteria, viruses and fungi [6] [7] [8] .
The study of aromatic plants in Colombia is supported by the enormous biodiversity of the country [9] . The pharmaceutical properties of aromatic plants are partially attributed to their EO composition. EOs have demonstrated activity against a wide spectrum of pathogenic microorganism such as Candida albicans, Salmonella typhyimurium, Escherichia coli and Herpes simplex virus [10] . Some EOs have shown important activity against M. tuberculosis [11] , including those from garlic (active at 1 µg mL -1 ), Laurus spp (active at 6.25 µg mL -1 ), Thymbra spicata (active at 128 µg mL -1 ), Thymus vulgaris (active at 50 µg mL -1 ) and Achyrocline alata (active at 62.5 µg mL -1 ) [11] [12] [13] [14] [15] .
Of the EOs used in this study that of Turnera diffusa has been reported to have antibacterial activity against Grampositive and Gram-negative bacteria [16] . T. diffusa and Lippia americana oils have been characterized in previous studies, the major constituents identified being β-pinene, β-caryophyllene oxide, cadinene, α-cadinol, 1,8-cineol, opoplenone, cadalene, epi-cubenol, and cadin-4-en-1-ol [17] [18] [19] The aim of this work was to evaluate the antimycobacterial and cell toxicity activities of the EOs derived from S. aratocensis, T. diffusa and L. americana, three aromatic plants of Colombia. The EOs were obtained by microwave-assisted hydrodistillation and analyzed by GC/MS techniques. They were isolated with yields of 0.5%, 0.7% and 0.5%, w/w, respectively. Tables 1 to 3 show their chemical compositions. The major components of the EO from S. aratocensis were epi-α-cadinol (20.1%) and 1,10-di-epi-cubenol (14.2%), of T. diffusa drima-7,9(11)-diene (22.9%) and viridiflorene (6.6%), and of L. americana trans-β-caryophyllene (11.3%) and germacrene D (15.4%).
The EO activities against the panel of 15 Mycobacterium strains are presented in Table 4 . The EO from S. aratocensis was the most active, followed by that of T. diffusa with MIC values below 125 µg mL -1 for M. tuberculosis strains (good activity below 100 µg mL -1 ); nontuberculous mycobacteria were more resistant to the three EOs with MIC values between 200 and 500 µg mL -1 ; M. tuberculosis H37Rv and M. chelonae were the most susceptible strains.
The time kill curves of S. aratocensis and T. diffusa against M. tuberculosis H37Rv and M. chelonae are shown in Figure 1 . Isoniazid and rifampin presented bactericidal activity against M. tuberculosis H37Rv at concentrations equivalent to 0.5-fold above the respective MIC; isoniazid was bacteriostatic against M. chelonae (data not shown). S. aratocensis and T. diffusa were bactericidal against both strains at concentrations equivalent to 2-fold above the respective MIC.
The EOs were either partially or non toxic to Vero and THP-1 mammalian cells with CC 50 activities in the range from 30 to >100 µg mL -1 and CC 90 activities >100 µg mL -1 . The EO from T. diffusa was the least active, being non-toxic to THP-1 cells at the maximal concentration used in this study. The need to counter bacterial resistance is obvious and pressing. Plants produce antibacterial metabolites as part of their chemical defense strategy to protect themselves against microbes in their environment [20] . Some species of soil bacteria, such as Streptomyces, are plant pathogens and these are taxonomically related to Mycobacterium species [20] . This study represents the first phase of ongoing research to identify new agents, which are safe and effective, for the treatment of TB both MDR and XDR as nontuberculous mycobacterial isolates.
Terpenes play an important role in the defense of many types of organisms, such as plants, fungi and certain marine organisms [21, 22] . Terpenes have been evaluated for their in vitro antimycobacterial activity [23] , especially thymol, with an antimycobacterial MIC of 100 µg mL -1 [13] . Other terpenes, such as carvacrol and α-pinene, have given MICs against M. tuberculosis H37Rv of 64 and 128 µg mL -1 , respectively [14] . Carvacrol was active too against M. avium strains, with a MIC of 72.2 µg mL -1 [24] . In addition, the antitubercular activity of citronellol, nerol and geraniol has been evaluated with MICs between 64-128 µg mL -1 [23] . Thus, the activity of the EOs examined could be attributed to their terpenoid content [25] , Similarly, EOs that were characterized by high levels of sesquiterpenes, such as γ-cadinene, (Z)-β-farnesene, γmuurolene, spathulenol, hexahydrofarnesyl acetone and αselinene, exhibited antifungal and antibacterial activity [25] .
Possibly, the antibacterial activity of terpenes is due to a perturbation of the microorganism lipid fraction of the plasma membrane, which results in alterations of membrane permeability and in leakage of intracellular materials, and as such impairs the energy metabolism and influences genetic material synthesis [26, 27] . Antimicrobial activity against Mycobacterium species depends on how efficiently the cell wall constitutes an efficient permeability barrier. The natural resistance to a wide range of antibiotics is often thought to be at least partially related to the poor penetration of solutes across the cell wall, It is also well known that the mycobacterial cell wall is extremely rich in lipids, principally in the form of very long-chain fatty acids (mycolic acids), which account for 30 to 60% of the weight of the wall. Such a thick layer of lipidic material obviously acts as a barrier to penetration of hydrophilic solutes. This fact can explain the differences between the low MICs obtained with M. tuberculosis strains and the high MIC values with nontuberculous mycobacterial species [28] . The EOs and their components are an interesting source of new antimycobacterial agents. EOs can be useful for the development of new biocidal agents for environmental mycobacterial control, for purifying air, personal hygiene, 
EO extraction:
The EOs were extracted from plant leaves and stems (300 g) by microwave-assisted hydrodistillation (30 min, 250 mL water), using a Clevenger-type distillation apparatus and a Dean-Stark distillation trap in a domestic microwave oven (Kendo, MO-124, 2,5 GHz, 800 W), as described elsewhere [29] . Sodium sulfate (Merck, Darmstadt, Germany) was added as a drying agent to the decanted essential oil. After extraction, the volume of essential oil obtained in both extractions was measured and the essential oil stored in hermetically sealed glass containers with rubber lids and maintained at a temperature lower than 4°C until used. 
Mammalian cells: Vero cells (ATCC) and human acute monocytic leukemia cell line THP-1 cells (ATCC)
were cultured in RPMI 1640 medium plus 10% heat inactivated fetal calf serum (hiFCS) at 37C and 5% CO 2 -95% air mixture.
Antimycobacterial activity:
The antimycobacterial activity of the essential oils was evaluated following the macrodilution protocol, described by Abate et al. and Bueno-Sánchez et al. [11, 30] . A microorganism suspension was prepared at a concentration of about 2x10 6 CFU (Colony Formation Units) mL -1 and further diluted 1:20 in Middlebrook 7H9 (Becton Dickinson and Co, Sparks MD, USA) medium supplemented with 10% OADC (oleic acidalbumin-dextrose-catalase) (Becton Dickinson and Co,, Sparks MD, USA) and 0.001% Tween 80 (Sigma, New Jersey, USA); 1 mL of the bacterial suspension was added to each glass tube with a cap, together with the EOs diluted to final concentrations from 31.25 to 500 µg mL -1 , adjusted to a final 2 mL volume. After incubation for about 7 days for slow growing mycobacteria (M. tuberculosis, M. abscessus, M. intracellulare, M. terrae and M. szulgai) and 5 days for rapid growing mycobacteria (M. chelonae and M. fortuitum), 100 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl tetrazolium bromide (MTT) (5 mg mL -1 ) (Sigma, New Jersey, USA) with 20% Tween 80 (Sigma, New Jersey, USA) were added to the glass tubes. A violet color indicates bacterial growth. The results were read in the following day. For standard tests, the MIC values of rifampin, isoniazid, streptomycin and ethambutol (Sigma, New Jersey, USA) were determined each time. The minimum inhibitory concentration (MIC) of each oil corresponded to the lowest concentration at which the bacteria tested did not show growth. Susceptibility testing was performed 3 times. The results are expressed as the mean obtained from 3 different assays.
Antimycobacterial time kill curves: Time-kill curves were used to measure the bactericidal activity of EOs with the lowest MIC values. Bactericidal activity was measured in glass tubes each containing 2 mL of Middlebrook 7H9 medium supplemented with OADC and Tween 80 at concentrations 0.5-, 1-, and 2-fold above the respective MIC; M. tuberculosis H37Rv and M. chelonae were used. The final concentration of mycobacteria was approximately 10 6 CFU mL -1 . Samples were taken each 2 days until the sixth day and were serially diluted in sterile distilled water in order to avoid any significant carry over and plated into Lowestein-Jensenn tubes with screw caps; tubes were incubated at 37ºC in an Incubator Shaker Model G25 (New Brunswick Scientific Co, New Jersey, USA). Isoniazid and rifampin were used as control drugs. The time-kill curve assay was carried out according to the recommendations of CLSI [31] .
Toxicity to mammalian cells: The cell toxicity was tested using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)] reduction assay following the protocol described by Escobar et al. [32] . Briefly, Vero and THP-1 cells were treated with each essential oil (0-100 g/mL) for 72 h. A solution of MTT (10 ng/mL) was added for 4 h and formazan crystals were dissolved with DMSO. The optical density (OD) was measured using a microplate reader at a wavelength of 580 nm. The cell toxicity was expressed as the concentration required for 50% and 90% (CC 50 and CC 90 ) cell kill. These were calculated by sigmoidal regression analyses (Msxlfit, ID Business Solution, Guildford, UK).
Statistical analysis:
MIC results were analyzed using Excel program and are expressed as geometric mean (GM). The results of kill-kinetic determinations are shown graphically by plotting log 10 CFUs against time and expressed as the mean. A bactericidal effect can be seen by a 3 log 10 (99.9% killing) decrease in CFU at the time specified.
